Cloud & Digital Solutions Adoption in Biopharma – Report 2022

How will life science companies harness cloud & digital solutions in 2022?

The continued drive for innovation and cost efficiency puts high pressure on the life science sector – especially the IT and R&D departments. While the average production costs of a biologic drug beat $22/day, biotech & pharma companies have to develop new digital solutions at speed and, of course, with regulatory challenges in mind.

Cloud Adoption Report 2022

We decided to explore the cloud & digital solution market and find out what awaits the bio-pharma IT departments in 2022.

In the report, you will find:

  • Cloud adoption dynamics 
  • Opportunities and risks for bio-pharma companies
  • List of top digital tools in biopharma manufacturing 

Click the image below and download the report

83% of enterprise workload is already in the cloud. Read the report "Cloud adoption in Bio-Pharma Manufacturing 2022. Download now